drugset / Trial / NCT01574131
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
Phase 4
Terminated
3 enrolled
The University of Texas Medical Branch, Galveston
Shriners Hospitals for Children · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to learn the following: whether long-term treatment (6 months) with fenofibrate will decrease burn related sugar and fat increased in the blood and help prevent muscle loss and improve wound healing.
Timeline
- Start
- 2012-05
- Primary completion
- 2016-02
- Completion
- 2016-02
Outcome
Outcome not reported
Stopped (Business): “lost funding; Shriner Burn Hosp has revoked access to study records. No updates or results can be submitted”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fenofibrate | Small molecule | 54 mg | — |
| Comparator | Fenofibrate | Small molecule | 160 mg | — |
Indications
No indication recorded.